135 related articles for article (PubMed ID: 38885783)
1. Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation.
Simitsis P; Nohria A; Kelleher J; Boulet J; Wanderley JMRB; Natarajan P; Libby P; Mehra MR
J Card Fail; 2024 Jun; ():. PubMed ID: 38885783
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis of indeterminate potential and outcomes after heart transplantation: A multicenter study.
Amancherla K; Schlendorf KH; Vlasschaert C; Lowery BD; Wells QS; See SB; Zorn E; Colombo PC; Reilly MP; Lindenfeld J; Uriel N; Freedman JE; Shah RV; Moslehi J; Bick AG; Clerkin K
Am J Transplant; 2023 Aug; 23(8):1256-1263. PubMed ID: 37156299
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
4. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
5. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
[TBL] [Abstract][Full Text] [Related]
6. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
7. Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
Ahn HJ; An HY; Ryu G; Lim J; Sun C; Song H; Choi SY; Lee H; Maurer T; Nachun D; Kwon S; Lee SR; Lip GYH; Oh S; Jaiswal S; Koh Y; Choi EK
Eur Heart J; 2024 Mar; 45(10):778-790. PubMed ID: 38231881
[TBL] [Abstract][Full Text] [Related]
8. Solid Organ Transplant Recipients Exhibit More TET2-Mutant Clonal Hematopoiesis of Indeterminate Potential Not Driven by Increased Transplantation Risk.
Silver AJ; Vlasschaert C; Mack T; Sharber B; Xu Y; Bick AG; Pinson CW; Savona MR
Clin Cancer Res; 2024 Jun; 30(11):2475-2485. PubMed ID: 38551504
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients.
Swaminathan AC; Barfield R; Zhang M; Povysil G; Chen C; Frankel C; Kelly F; McKinney M; Todd JL; Allen A; Palmer SM
BMC Pulm Med; 2023 Oct; 23(1):414. PubMed ID: 37904125
[TBL] [Abstract][Full Text] [Related]
10. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
11. Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.
Scolari FL; Brahmbhatt DH; Abelson S; Medeiros JJF; Anker MS; Fung NL; Otsuki M; Calvillo-Argüelles O; Lawler PR; Ross HJ; Luk AC; Anker S; Dick JE; Billia F
Am J Transplant; 2022 Dec; 22(12):3078-3086. PubMed ID: 35971851
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.
Kim KH; Kim T; Novitzky-Basso I; Lee H; Yoo Y; Ahn JS; Pasic I; Law A; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Zhang Z; Kaushansky N; Brilon Y; Chapal-Ilani N; Biezuner T; Shlush LI; Kim DDH
Haematologica; 2023 Jul; 108(7):1817-1826. PubMed ID: 36727396
[TBL] [Abstract][Full Text] [Related]
13. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
17. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
18. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review.
Senguttuvan NB; Subramanian V; Venkatesan V; Muralidharan TR; Sankaranarayanan K
J Genet Eng Biotechnol; 2021 Jul; 19(1):105. PubMed ID: 34279740
[TBL] [Abstract][Full Text] [Related]
19. Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry.
Gillis N; Padron E; Wang T; Chen K; DeVos JD; Spellman SR; Lee SJ; Kitko CL; MacMillan ML; West J; Tang YH; Teng M; McNulty S; Druley TE; Pidala JA; Lazaryan A
Transplant Cell Ther; 2023 Oct; 29(10):640.e1-640.e8. PubMed ID: 37517612
[TBL] [Abstract][Full Text] [Related]
20. Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant.
Rhee JW; Pillai R; He T; Bosworth A; Chen S; Atencio L; Oganesyan A; Peng K; Guzman T; Lukas K; Sigala B; Iukuridze A; Lindenfeld L; Jamal F; Natarajan P; Goldsmith S; Krishnan A; Rosenzweig M; Wong FL; Forman SJ; Armenian S
JAMA Cardiol; 2024 Jan; 9(1):16-24. PubMed ID: 37938837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
